4:53 PM
 | 
Jan 02, 2014
 |  BC Extra  |  Financial News

Alexar debuts with $21.5 million in series A

Alexar Therapeutics Inc. (Malvern, Pa.) debuted with $21.5 million secured in a series A round led by New Science Ventures...

Read the full 79 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >